It turned out to be especially valuable for superficial G2/G3 patients at a high risk for muscular invasion, indicating that UCA1 may be a new promising urinary biomarker for the diagnosis of bladder cancer. H19 expression levels are remarkably increased in bladder carcinomas compared to normal tissue and could also serve as another biomarker. Here, UCA1 is linked to urinary bladder carcinoma.